Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced U.S. availability of ...

New research uncovers how obesity amplifies long COVID risks and why smoking's impact may be limited to memory problems, providing fresh insights into post-COVID health challenges. Study: Influence of ...

Persistent radiologic abnormalities after COVID-19 were common 28-60 days post-discharge, often showing improvement but remaining linked to long-term health quality, highlighting a population ...

Disrupted sleep and anxiety may be ongoing issues for many people after the pandemic, whether due to COVID-19 directly or to ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...